SlideShare a Scribd company logo
1 of 1
Download to read offline
Retrospective Analysis of Pregnancy and Neonatal Outcome
with Low and Very Low Papp-a on First Trimester Screen
V. Lozovyy, MD, D. Bradke, BS, J. King, BS, F. Schubert, MPH, K. Fitzpatrick, MD, S. Singh, MD
Department of Obstetrics and Gynecology, NYU Lutheran Medical Center, Brooklyn, NY
Introduction
v Low PAPP-A is a marker for Trisomy
21,13 and 18.
v Studies have shown some association
between low PAPP-A and higher rates
of adverse pregnancy outcomes such
as poor fetal growth, low birth weight,
pre-eclampsia and stillbirth.
v The goal of this study was to determine
whether differences in PAPP- A among
patients with low birth weight between
1st and 5th percentiles and very low birth
weight < 1st percentile are clinically
significant in predicting perinatal and
pregnancy adverse outcomes.
Methods
v A retrospective review of 2588 women
referred to the Maternal Fetal Medicine
Unit at NYU Lutheran Medical Center
between November 2011 and March
2015 for evaluation of first-trimester risk
assessment.
v Women who had low PAPP-A, less than
5th percentile, were included totaling
236 women enrolled in the study.
v Biochemical risk assessment was
performed from 9 0/7 -13 6/7 weeks.
v Pregnancy outcome was determined
from medical records and New York
Department of Health Birth Registry.
v Data were analyzed using one sample
t- test. P < 0.05 was significant.
Limitations and Strengths
v Small sample size
v Retrospective analysis
Conclusions
Within the cohort of patients with PAPP-A
under the 5th and 1st percentile, no adverse
perinatal outcome was found except for
preterm delivery rate of 13.6%. Further
analysis revealed that there is a statistically
significant association between lower PAPP-A
and incidence of preterm births. We can
conclude that increased fetal surveillance is
still required for patients with low PAPP-A.
In an effort to reduce the unnecessary
intervention in patients that are associated with
increased fetal surveillance, we will seek
through future studies to further stratify these
patients based on additional risk factors.
Utilizing the data in this study we believe that
we can optimize patient care while
simultaneously saving health care costs.
Maternal	and	
Neonatal	
Characteristics
Outcome	(n)
Weeks	Gestational	
age	(GA)
38.1	 2.2	
(236)	
Weeks	GA	at	the	Last	
Biometry
30.9	 6.6	
(226)	
EFW	Percentile	at	
the	Last	Biometry
42.8	 22.2	
(222)	
NSVD 70.3%	(166)
Cesarean	Delivery 29.7%	(70)
Pre-eclampsia 17.8%		(42)
Neonatal	
Birth	Weight
3096	 553	
(236)	
IUGR	incidence
(<	10th percentile)
9.3%	(22)
Preterm	Births 13.6%	(32)
APGAR	at	1	Minute	 8.6	1.2	(236)
APGAR	at	5	Minutes 8.8	 0.8	(236)	
NICU	Admission 0.4%	(1)
Table 1: Total study maternal & neonatal statistics
Table 2: Statistics within Low PAPP-A cohorts
>1st and	≤5th
Percentile
<1st
percentile	
Preterm	
Births
11.3%	(20) 20.3%	(12)
Cohort	
Breakdown
75%	(177) 25%	(59)
Results
v 236 women were included. 9% incidence.
v The mean GA was 38.1 + 2.2.
v The mean birth weight was 3097 + 553.
v The mean gestational age at the time of the
last biometric measurement was 30.9
weeks + 7 days.
v Estimated fetal weight percentile at the last
growth scan was 42.8 (+22.2) percent.
v APGAR score at 5 minutes was 8.8 + 0.8 in
90% of neonates.
v One neonate (0.4%) required NICU
admission.
v Rate of preterm birth was observed in
13.6% of cohort vs. 9.6% nationally in 2015
(p=0.03) with 95% CI (9.50 to 18.64).
v Preterm birth rate was more common in the
very low PAPP-A group 20.3% compared
to low PAPP-A group 11.3% with no
statistical difference between groups
(p=0.079).
v There was no statistical association
between pre-eclampsia and PAPP-A levels.

More Related Content

What's hot

Endometrial Receptivity in eutopic endometrium in endometriosis
Endometrial Receptivity in eutopic endometrium in endometriosisEndometrial Receptivity in eutopic endometrium in endometriosis
Endometrial Receptivity in eutopic endometrium in endometriosis
Mediana Sutopo L
 
Other potential definitions of success in art itt, et, (1)
Other potential definitions of success in art itt, et, (1)Other potential definitions of success in art itt, et, (1)
Other potential definitions of success in art itt, et, (1)
鋒博 蔡
 

What's hot (16)

UOG Journal Club: Analysis of cell-free DNA in maternal blood in screening fo...
UOG Journal Club: Analysis of cell-free DNA in maternal blood in screening fo...UOG Journal Club: Analysis of cell-free DNA in maternal blood in screening fo...
UOG Journal Club: Analysis of cell-free DNA in maternal blood in screening fo...
 
UOG Journal Club: Screening for trisomies 21, 18 and 13 by cell-free DNA anal...
UOG Journal Club: Screening for trisomies 21, 18 and 13 by cell-free DNA anal...UOG Journal Club: Screening for trisomies 21, 18 and 13 by cell-free DNA anal...
UOG Journal Club: Screening for trisomies 21, 18 and 13 by cell-free DNA anal...
 
UOG Journal Club: Poor neonatal acid–base status in term fetuses with low cer...
UOG Journal Club: Poor neonatal acid–base status in term fetuses with low cer...UOG Journal Club: Poor neonatal acid–base status in term fetuses with low cer...
UOG Journal Club: Poor neonatal acid–base status in term fetuses with low cer...
 
UOG Journal Club: Perinatal morbidity and mortality in early-onset fetal grow...
UOG Journal Club: Perinatal morbidity and mortality in early-onset fetal grow...UOG Journal Club: Perinatal morbidity and mortality in early-onset fetal grow...
UOG Journal Club: Perinatal morbidity and mortality in early-onset fetal grow...
 
ppt
pptppt
ppt
 
Dr Ayman Ewies - Postcoital Bleeding National Survey
Dr Ayman Ewies - Postcoital Bleeding National SurveyDr Ayman Ewies - Postcoital Bleeding National Survey
Dr Ayman Ewies - Postcoital Bleeding National Survey
 
Jc aprile 2017
Jc aprile 2017Jc aprile 2017
Jc aprile 2017
 
UOG Journal Club: Reassessing critical maternal antibody threshold in RhD all...
UOG Journal Club: Reassessing critical maternal antibody threshold in RhD all...UOG Journal Club: Reassessing critical maternal antibody threshold in RhD all...
UOG Journal Club: Reassessing critical maternal antibody threshold in RhD all...
 
Breastfeeding domeperiodne
Breastfeeding domeperiodneBreastfeeding domeperiodne
Breastfeeding domeperiodne
 
Final Oocyte Maturation: HCG VS GNRH Agonist by Dr. Abayomi Ajayi
Final Oocyte Maturation: HCG VS GNRH Agonist by Dr. Abayomi AjayiFinal Oocyte Maturation: HCG VS GNRH Agonist by Dr. Abayomi Ajayi
Final Oocyte Maturation: HCG VS GNRH Agonist by Dr. Abayomi Ajayi
 
UOG Journal Club: Perinatal and long-term outcomes in fetuses diagnosed with ...
UOG Journal Club: Perinatal and long-term outcomes in fetuses diagnosed with ...UOG Journal Club: Perinatal and long-term outcomes in fetuses diagnosed with ...
UOG Journal Club: Perinatal and long-term outcomes in fetuses diagnosed with ...
 
Endometrial Receptivity in eutopic endometrium in endometriosis
Endometrial Receptivity in eutopic endometrium in endometriosisEndometrial Receptivity in eutopic endometrium in endometriosis
Endometrial Receptivity in eutopic endometrium in endometriosis
 
(마더리스크라운드) Breastfeeding
(마더리스크라운드) Breastfeeding (마더리스크라운드) Breastfeeding
(마더리스크라운드) Breastfeeding
 
02 Changing midwifery practices
02  Changing midwifery practices02  Changing midwifery practices
02 Changing midwifery practices
 
UOG Journal Club: GnRH agonist during luteal phase in women undergoing assist...
UOG Journal Club: GnRH agonist during luteal phase in women undergoing assist...UOG Journal Club: GnRH agonist during luteal phase in women undergoing assist...
UOG Journal Club: GnRH agonist during luteal phase in women undergoing assist...
 
Other potential definitions of success in art itt, et, (1)
Other potential definitions of success in art itt, et, (1)Other potential definitions of success in art itt, et, (1)
Other potential definitions of success in art itt, et, (1)
 

Similar to PAPPA ACOG Poster

NEW_How to Improve Endometrium Receptivity (1).pptx
NEW_How to Improve Endometrium Receptivity (1).pptxNEW_How to Improve Endometrium Receptivity (1).pptx
NEW_How to Improve Endometrium Receptivity (1).pptx
tikaaprilia3
 
Umbilical cord magnesium levels and neonatal resuscitation in infants exposed...
Umbilical cord magnesium levels and neonatal resuscitation in infants exposed...Umbilical cord magnesium levels and neonatal resuscitation in infants exposed...
Umbilical cord magnesium levels and neonatal resuscitation in infants exposed...
Maria Adelus
 
NH ACOG poster
NH ACOG posterNH ACOG poster
NH ACOG poster
Jade King
 
Role of progesterone in Pregnancy
Role of progesterone in Pregnancy Role of progesterone in Pregnancy
Role of progesterone in Pregnancy
Lifecare Centre
 
Data Search TableKeywordParametersCINAHLPubMedMedline
Data Search TableKeywordParametersCINAHLPubMedMedlineData Search TableKeywordParametersCINAHLPubMedMedline
Data Search TableKeywordParametersCINAHLPubMedMedline
OllieShoresna
 

Similar to PAPPA ACOG Poster (20)

Management-of-Postterm-Pregnancy
Management-of-Postterm-PregnancyManagement-of-Postterm-Pregnancy
Management-of-Postterm-Pregnancy
 
The Relationship between Maternal Anemia and Birth Weight in New Born
The Relationship between Maternal Anemia and Birth Weight in New BornThe Relationship between Maternal Anemia and Birth Weight in New Born
The Relationship between Maternal Anemia and Birth Weight in New Born
 
NEW_How to Improve Endometrium Receptivity (1).pptx
NEW_How to Improve Endometrium Receptivity (1).pptxNEW_How to Improve Endometrium Receptivity (1).pptx
NEW_How to Improve Endometrium Receptivity (1).pptx
 
Umbilical cord magnesium levels and neonatal resuscitation in infants exposed...
Umbilical cord magnesium levels and neonatal resuscitation in infants exposed...Umbilical cord magnesium levels and neonatal resuscitation in infants exposed...
Umbilical cord magnesium levels and neonatal resuscitation in infants exposed...
 
Murray2005
Murray2005Murray2005
Murray2005
 
Initial Typeset
Initial TypesetInitial Typeset
Initial Typeset
 
Initial Typeset
Initial TypesetInitial Typeset
Initial Typeset
 
aspirina.pdf anticoagulante en el tratamiento
aspirina.pdf anticoagulante en el tratamientoaspirina.pdf anticoagulante en el tratamiento
aspirina.pdf anticoagulante en el tratamiento
 
Vai trò của chỉ số não rốn trong đánh giá sức khỏe thai nhi ở thai AGA và SGA
Vai trò của chỉ số não rốn trong đánh giá sức khỏe thai nhi ở thai AGA và SGA Vai trò của chỉ số não rốn trong đánh giá sức khỏe thai nhi ở thai AGA và SGA
Vai trò của chỉ số não rốn trong đánh giá sức khỏe thai nhi ở thai AGA và SGA
 
NH ACOG poster
NH ACOG posterNH ACOG poster
NH ACOG poster
 
Role of progesterone in Pregnancy
Role of progesterone in Pregnancy Role of progesterone in Pregnancy
Role of progesterone in Pregnancy
 
3002.pdf
3002.pdf3002.pdf
3002.pdf
 
Neonatal Outcome In Pregnancy Induced Hypertensive Mothers – A Tertiary Care ...
Neonatal Outcome In Pregnancy Induced Hypertensive Mothers – A Tertiary Care ...Neonatal Outcome In Pregnancy Induced Hypertensive Mothers – A Tertiary Care ...
Neonatal Outcome In Pregnancy Induced Hypertensive Mothers – A Tertiary Care ...
 
Data Search TableKeywordParametersCINAHLPubMedMedline
Data Search TableKeywordParametersCINAHLPubMedMedlineData Search TableKeywordParametersCINAHLPubMedMedline
Data Search TableKeywordParametersCINAHLPubMedMedline
 
Prediction and prevention of preeclampsia
Prediction and prevention of preeclampsiaPrediction and prevention of preeclampsia
Prediction and prevention of preeclampsia
 
Hypertensionin pregnancy ACOG Actualización diciembre 2013
Hypertensionin pregnancy ACOG Actualización diciembre 2013Hypertensionin pregnancy ACOG Actualización diciembre 2013
Hypertensionin pregnancy ACOG Actualización diciembre 2013
 
A COMPARATIVE ANALYSIS OF HEMATOLOGICAL INDICES IN PREGNANT WOMEN AND NON PR...
A COMPARATIVE ANALYSIS OF HEMATOLOGICAL INDICES IN  PREGNANT WOMEN AND NON PR...A COMPARATIVE ANALYSIS OF HEMATOLOGICAL INDICES IN  PREGNANT WOMEN AND NON PR...
A COMPARATIVE ANALYSIS OF HEMATOLOGICAL INDICES IN PREGNANT WOMEN AND NON PR...
 
final edit
final editfinal edit
final edit
 
Effect of Anemia on Pregnancy outcome: A Case-control study
Effect of Anemia on Pregnancy outcome: A Case-control studyEffect of Anemia on Pregnancy outcome: A Case-control study
Effect of Anemia on Pregnancy outcome: A Case-control study
 
Obstetric outcomes associated with second trimester unexplained abnormal mate...
Obstetric outcomes associated with second trimester unexplained abnormal mate...Obstetric outcomes associated with second trimester unexplained abnormal mate...
Obstetric outcomes associated with second trimester unexplained abnormal mate...
 

PAPPA ACOG Poster

  • 1. Retrospective Analysis of Pregnancy and Neonatal Outcome with Low and Very Low Papp-a on First Trimester Screen V. Lozovyy, MD, D. Bradke, BS, J. King, BS, F. Schubert, MPH, K. Fitzpatrick, MD, S. Singh, MD Department of Obstetrics and Gynecology, NYU Lutheran Medical Center, Brooklyn, NY Introduction v Low PAPP-A is a marker for Trisomy 21,13 and 18. v Studies have shown some association between low PAPP-A and higher rates of adverse pregnancy outcomes such as poor fetal growth, low birth weight, pre-eclampsia and stillbirth. v The goal of this study was to determine whether differences in PAPP- A among patients with low birth weight between 1st and 5th percentiles and very low birth weight < 1st percentile are clinically significant in predicting perinatal and pregnancy adverse outcomes. Methods v A retrospective review of 2588 women referred to the Maternal Fetal Medicine Unit at NYU Lutheran Medical Center between November 2011 and March 2015 for evaluation of first-trimester risk assessment. v Women who had low PAPP-A, less than 5th percentile, were included totaling 236 women enrolled in the study. v Biochemical risk assessment was performed from 9 0/7 -13 6/7 weeks. v Pregnancy outcome was determined from medical records and New York Department of Health Birth Registry. v Data were analyzed using one sample t- test. P < 0.05 was significant. Limitations and Strengths v Small sample size v Retrospective analysis Conclusions Within the cohort of patients with PAPP-A under the 5th and 1st percentile, no adverse perinatal outcome was found except for preterm delivery rate of 13.6%. Further analysis revealed that there is a statistically significant association between lower PAPP-A and incidence of preterm births. We can conclude that increased fetal surveillance is still required for patients with low PAPP-A. In an effort to reduce the unnecessary intervention in patients that are associated with increased fetal surveillance, we will seek through future studies to further stratify these patients based on additional risk factors. Utilizing the data in this study we believe that we can optimize patient care while simultaneously saving health care costs. Maternal and Neonatal Characteristics Outcome (n) Weeks Gestational age (GA) 38.1 2.2 (236) Weeks GA at the Last Biometry 30.9 6.6 (226) EFW Percentile at the Last Biometry 42.8 22.2 (222) NSVD 70.3% (166) Cesarean Delivery 29.7% (70) Pre-eclampsia 17.8% (42) Neonatal Birth Weight 3096 553 (236) IUGR incidence (< 10th percentile) 9.3% (22) Preterm Births 13.6% (32) APGAR at 1 Minute 8.6 1.2 (236) APGAR at 5 Minutes 8.8 0.8 (236) NICU Admission 0.4% (1) Table 1: Total study maternal & neonatal statistics Table 2: Statistics within Low PAPP-A cohorts >1st and ≤5th Percentile <1st percentile Preterm Births 11.3% (20) 20.3% (12) Cohort Breakdown 75% (177) 25% (59) Results v 236 women were included. 9% incidence. v The mean GA was 38.1 + 2.2. v The mean birth weight was 3097 + 553. v The mean gestational age at the time of the last biometric measurement was 30.9 weeks + 7 days. v Estimated fetal weight percentile at the last growth scan was 42.8 (+22.2) percent. v APGAR score at 5 minutes was 8.8 + 0.8 in 90% of neonates. v One neonate (0.4%) required NICU admission. v Rate of preterm birth was observed in 13.6% of cohort vs. 9.6% nationally in 2015 (p=0.03) with 95% CI (9.50 to 18.64). v Preterm birth rate was more common in the very low PAPP-A group 20.3% compared to low PAPP-A group 11.3% with no statistical difference between groups (p=0.079). v There was no statistical association between pre-eclampsia and PAPP-A levels.